Srinivas Tallapragada - Jun 22, 2022 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
Pres/Chief Engineering Officer
Signature
/s/ Anisha Sharodi, Attorney-in-Fact for Srinivas Tallapragada
Stock symbol
CRM
Transactions as of
Jun 22, 2022
Transactions value $
-$157,476
Form type
4
Date filed
6/23/2022, 08:50 PM
Previous filing
Jun 9, 2022
Next filing
Jul 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $0 +967 +2.04% $0.00 48.3K Jun 22, 2022 Direct
transaction CRM Common Stock Options Exercise $0 +871 +1.8% $0.00 49.1K Jun 22, 2022 Direct
transaction CRM Common Stock Sale -$157K -924 -1.88% $170.43 48.2K Jun 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Restricted Stock Units Options Exercise $0 -967 -24.99% $0.00 2.9K Jun 22, 2022 Common Stock 967 $0.00 Direct F2, F3
transaction CRM Restricted Stock Units Options Exercise $0 -871 -8.33% $0.00 9.59K Jun 22, 2022 Common Stock 871 $0.00 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through June 22, 2022.
F2 Restricted Stock Units convert to shares of common stock on a one-for-one basis.
F3 These restricted stock units vested as to 25% of the original grant on March 22, 2020 and vest as to 1/16 of the original grant quarterly thereafter.
F4 These restricted stock units vested as to 25% of the original grant on March 22, 2022 and vest as to 1/16 of the original grant quarterly thereafter.